Year |
Citation |
Score |
2024 |
Oztan O, Del Rosso LA, Simmons SM, Nguyen DKK, Talbot CF, Capitanio JP, Garner JP, Parker KJ. Naturally occurring low sociality in female rhesus monkeys: A tractable model for autism or not? Molecular Autism. 15: 8. PMID 38291493 DOI: 10.1186/s13229-024-00588-3 |
0.77 |
|
2022 |
Oztan O, Zyga O, Stafford DEJ, Parker KJ. Linking oxytocin and arginine vasopressin signaling abnormalities to social behavior impairments in Prader-Willi syndrome. Neuroscience and Biobehavioral Reviews. 104870. PMID 36113782 DOI: 10.1016/j.neubiorev.2022.104870 |
0.586 |
|
2021 |
Oztan O, Talbot CF, Argilli E, Maness AC, Simmons SM, Mohsin N, Del Rosso LA, Garner JP, Sherr EH, Capitanio JP, Parker KJ. Autism-associated biomarkers: test-retest reliability and relationship to quantitative social trait variation in rhesus monkeys. Molecular Autism. 12: 50. PMID 34238350 DOI: 10.1186/s13229-021-00442-w |
0.77 |
|
2020 |
Isgor C, Aydin C, Oztan O, Libreros S, Iragavarapu-Charyulu V. Inter-individual differences in immune profiles of outbred rats screened for an emotional reactivity phenotype. Journal of Neuroimmunology. 347: 577349. PMID 32750564 DOI: 10.1016/J.Jneuroim.2020.577349 |
0.745 |
|
2020 |
Oztan O, Garner JP, Constantino JN, Parker KJ. Neonatal CSF vasopressin concentration predicts later medical record diagnoses of autism spectrum disorder. Proceedings of the National Academy of Sciences of the United States of America. PMID 32341146 DOI: 10.1073/Pnas.1919050117 |
0.609 |
|
2019 |
Mariscal MG, Oztan O, Rose SM, Libove RA, Jackson LP, Sumiyoshi RD, Trujillo TH, Carson DS, Phillips JM, Garner JP, Hardan AY, Parker KJ. Blood oxytocin concentration positively predicts contagious yawning behavior in children with autism spectrum disorder. Autism Research : Official Journal of the International Society For Autism Research. PMID 31132232 DOI: 10.1002/Aur.2135 |
0.761 |
|
2019 |
Parker KJ, Oztan O, Libove RA, Mohsin N, Karhson DS, Sumiyoshi RD, Summers JE, Hinman KE, Motonaga KS, Phillips JM, Carson DS, Fung LK, Garner JP, Hardan AY. A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism. Science Translational Medicine. PMID 31043522 DOI: 10.1126/Scitranslmed.Aau7356 |
0.773 |
|
2018 |
Oztan O, Garner JP, Partap S, Sherr EH, Hardan AY, Farmer C, Thurm A, Swedo SE, Parker KJ. Cerebrospinal fluid vasopressin and symptom severity in children with autism. Annals of Neurology. PMID 30152888 DOI: 10.1002/Ana.25314 |
0.638 |
|
2018 |
Parker KJ, Garner JP, Oztan O, Tarara ER, Li J, Sclafani V, Del Rosso LA, Chun K, Berquist SW, Chez MG, Partap S, Hardan AY, Sherr EH, Capitanio JP. Arginine vasopressin in cerebrospinal fluid is a marker of sociality in nonhuman primates. Science Translational Medicine. 10. PMID 29720452 DOI: 10.1126/Scitranslmed.Aam9100 |
0.798 |
|
2017 |
Oztan O, Jackson LP, Libove RA, Sumiyoshi RD, Phillips JM, Garner JP, Hardan AY, Parker KJ. Biomarker discovery for disease status and symptom severity in children with autism. Psychoneuroendocrinology. 89: 39-45. PMID 29309996 DOI: 10.1016/J.Psyneuen.2017.12.022 |
0.623 |
|
2017 |
Madrid JE, Oztan O, Sclafani V, Del Rosso LA, Calonder LA, Chun K, Capitanio JP, Garner JP, Parker KJ. Preference for novel faces in male infant monkeys predicts cerebrospinal fluid oxytocin concentrations later in life. Scientific Reports. 7: 12935. PMID 29021623 DOI: 10.1038/S41598-017-13109-5 |
0.704 |
|
2017 |
Parker KJ, Oztan O, Libove RA, Sumiyoshi RD, Jackson LP, Karhson DS, Summers JE, Hinman KE, Motonaga KS, Phillips JM, Carson DS, Garner JP, Hardan AY. Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism. Proceedings of the National Academy of Sciences of the United States of America. PMID 28696286 DOI: 10.1073/Pnas.1705521114 |
0.775 |
|
2014 |
Aydin C, Oztan O, Isgor C. Hippocampal Y2 receptor-mediated mossy fiber plasticity is implicated in nicotine abstinence-related social anxiety-like behavior in an outbred rat model of the novelty-seeking phenotype. Pharmacology, Biochemistry, and Behavior. 125: 48-54. PMID 25158103 DOI: 10.1016/J.Pbb.2014.08.004 |
0.807 |
|
2012 |
Aydin C, Oztan O, Isgor C. Nicotine-induced anxiety-like behavior in a rat model of the novelty-seeking phenotype is associated with long-lasting neuropeptidergic and neuroplastic adaptations in the amygdala: effects of the cannabinoid receptor 1 antagonist AM251. Neuropharmacology. 63: 1335-45. PMID 22959963 DOI: 10.1016/J.Neuropharm.2012.08.016 |
0.795 |
|
2012 |
Aydin C, Oztan O, Isgor C. Long-term effects of juvenile nicotine exposure on abstinence-related social anxiety-like behavior and amygdalar cannabinoid receptor 1 (CB1R) mRNA expression in the novelty-seeking phenotype. Behavioural Brain Research. 228: 236-9. PMID 22119710 DOI: 10.1016/J.Bbr.2011.11.015 |
0.802 |
|
2011 |
Oztan O, Aydin C, Isgor C. Chronic variable physical stress during the peripubertal-juvenile period causes differential depressive and anxiogenic effects in the novelty-seeking phenotype: functional implications for hippocampal and amygdalar brain-derived neurotrophic factor and the mossy fibre plasticity. Neuroscience. 192: 334-44. PMID 21767611 DOI: 10.1016/J.Neuroscience.2011.06.077 |
0.771 |
|
2011 |
Oztan O, Aydin C, Isgor C. Stressful environmental and social stimulation in adolescence causes antidepressant-like effects associated with epigenetic induction of the hippocampal BDNF and mossy fibre sprouting in the novelty-seeking phenotype. Neuroscience Letters. 501: 107-11. PMID 21767606 DOI: 10.1016/J.Neulet.2011.06.058 |
0.789 |
|
2011 |
Aydin C, Oztan O, Isgor C. Effects of a selective Y2R antagonist, JNJ-31020028, on nicotine abstinence-related social anxiety-like behavior, neuropeptide Y and corticotropin releasing factor mRNA levels in the novelty-seeking phenotype. Behavioural Brain Research. 222: 332-41. PMID 21497168 DOI: 10.1016/J.Bbr.2011.03.067 |
0.809 |
|
2011 |
Aydin C, Oztan O, Isgor C. Vulnerability to nicotine abstinence-related social anxiety-like behavior: molecular correlates in neuropeptide Y, Y2 receptor and corticotropin releasing factor. Neuroscience Letters. 490: 220-5. PMID 21195134 DOI: 10.1016/J.Neulet.2010.12.056 |
0.81 |
|
2009 |
Bhatti AS, Aydin C, Oztan O, Ma Z, Hall P, Tao R, Isgor C. Effects of a cannabinoid receptor (CB) 1 antagonist AM251 on behavioral sensitization to nicotine in a rat model of novelty-seeking behavior: correlation with hippocampal 5HT. Psychopharmacology. 203: 23-32. PMID 18936914 DOI: 10.1007/S00213-008-1366-6 |
0.777 |
|
Show low-probability matches. |